• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problem Fluid/Blood Leak (1250)
Patient Problem Failure of Implant (1924)
Event Date 06/04/2018
Event Type  malfunction  
Manufacturer Narrative
The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.Device labeling addresses the reported event as follows: warnings and precautions: deflated devices should be removed promptly.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, acute pancreatitis, spontaneous inflation, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.If it is necessary to replace a balloon which has spontaneously deflated, the recommended initial fill volume of the replacement balloon is the same as for the first balloon or the most recent volume of the removed balloon.A greater initial fill volume in the replacement balloon may result in severe nausea, vomiting or ulcer formation.Possible complications of the use of the orbera® system include: balloon deflation and subsequent replacement.
 
Event Description
Reported as: a patient with the orbera intragastric balloon had colored urine.Device was removed and replaced.
 
Manufacturer Narrative
Supplement #1: medwatch sent to fda on 01/25/2019.Additional information: device evaluation summary: a visual examination was performed on the returned balloon.The balloon shell was noted to be discolored, as it was green in appearance.One opening was noted on the anterior portion of the balloon shell.Brown particles were noted on the inner surface of the valve channel.As the device was not received with the fill tube, a sample fill tube was used for device testing.A valve test was performed, and the flow of di water was continuous and unobstructed.An air leak test was performed, and leakage was noted from several openings on the balloon shell.Under microscopic analysis, six openings were noted on the shell: three on the anterior portion, and three on the posterior portion.All openings were noted to have striated edges, consistent with damage from a surgical tool.A non-penetrating nick/mark was noted on the anterior portion of the shell.Brown particles were noted on the inner surface of the valve channel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
MDR Report Key8118265
MDR Text Key129192614
Report Number3006722112-2018-00310
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 01/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/07/2018
Device Model NumberB-50000
Device Catalogue NumberB-50000
Device Lot Number2920468
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/26/2018
Initial Date Manufacturer Received 11/01/2018
Initial Date FDA Received11/29/2018
Supplement Dates Manufacturer Received01/11/2019
Supplement Dates FDA Received01/25/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age24 YR
-
-